Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 2
2005 1
2006 1
2007 4
2008 1
2009 4
2010 2
2011 2
2012 6
2013 12
2014 11
2015 16
2016 17
2017 16
2018 19
2019 13
2020 21
2021 21
2022 26
2023 31
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Type 1 diabetes mellitus 15"
Page 1
Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses.
Reynolds AN, Akerman AP, Mann J. Reynolds AN, et al. PLoS Med. 2020 Mar 6;17(3):e1003053. doi: 10.1371/journal.pmed.1003053. eCollection 2020 Mar. PLoS Med. 2020. PMID: 32142510 Free PMC article.
These benefits were not confined to any fibre type or to any type of diabetes and were apparent across the range of intakes, although greater improvements in glycaemic control were observed for those moving from low to moderate or high intakes. Based on these findings, increasing …
These benefits were not confined to any fibre type or to any type of diabetes and were apparent across the range of intakes, although greate …
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review.
de Filette JMK, Pen JJ, Decoster L, Vissers T, Bravenboer B, Van der Auwera BJ, Gorus FK, Roep BO, Aspeslagh S, Neyns B, Velkeniers B, Kharagjitsingh AV. de Filette JMK, et al. Eur J Endocrinol. 2019 Sep;181(3):363-374. doi: 10.1530/EJE-19-0291. Eur J Endocrinol. 2019. PMID: 31330498 Free PMC article.
Most patients were treated with anti-PD-1 or anti-PD-L1 as monotherapy (79%) or in combination with CTLA-4 blockade (15%). On average, diabetes mellitus was diagnosed after 4.5 cycles; earlier for combination ICI at 2.7 cycles. ...
Most patients were treated with anti-PD-1 or anti-PD-L1 as monotherapy (79%) or in combination with CTLA-4 blockade (15%). On average …
Clinical Improvements by Telemedicine Interventions Managing Type 1 and Type 2 Diabetes: Systematic Meta-review.
Eberle C, Stichling S. Eberle C, et al. J Med Internet Res. 2021 Feb 19;23(2):e23244. doi: 10.2196/23244. J Med Internet Res. 2021. PMID: 33605889 Free PMC article.
OBJECTIVE: This study aims to examine whether telemedical interventions effectively improve diabetes control using studies that pooled patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), and whether the benefits are great …
OBJECTIVE: This study aims to examine whether telemedical interventions effectively improve diabetes control using studies that pooled patie …
Diabetic ketoacidosis fluid management in children: systematic review and meta-analyses.
Hamud AA, Mudawi K, Shamekh A, Kadri A, Powell C, Abdelgadir I. Hamud AA, et al. Arch Dis Child. 2022 Nov;107(11):1023-1028. doi: 10.1136/archdischild-2022-324042. Epub 2022 Jun 23. Arch Dis Child. 2022. PMID: 35738870
IMPORTANCE: Diabetic ketoacidosis (DKA) is a serious complication of type 1 diabetes mellitus, which may lead to significant morbidity and mortality. ...No evidence of difference was noted in the GCS reduction (risk ratio (RR)=0.77, 95% CI 0.44 to 1.36 …
IMPORTANCE: Diabetic ketoacidosis (DKA) is a serious complication of type 1 diabetes mellitus, which may lead to …
Safety and Efficacy of Teplizumab for Treatment of Type One Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Nourelden AZ, Elshanbary AA, El-Sherif L, Benmelouka AY, Rohim HI, Helmy SK, Sayed MK, Ismail A, Ali AS, Ragab KM, Zaazouee MS. Nourelden AZ, et al. Endocr Metab Immune Disord Drug Targets. 2021;21(10):1895-1904. doi: 10.2174/1871530320999201209222921. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 33302842
The area under the curve of C-peptide was significantly increased in teplizumab group at 12 months (MD = 0.08, 95% CI [0.01, 0.15], P = 0.03), 18 months (MD = 0.13, 95% CI [0.01, 0.25], P = 0.03) and 24 months (MD = 0.13, 95% CI [0.01, 0.24], P = 0.03). ...
The area under the curve of C-peptide was significantly increased in teplizumab group at 12 months (MD = 0.08, 95% CI [0.01, 0.15], P …
Diet during pregnancy and infancy and risk of allergic or autoimmune disease: A systematic review and meta-analysis.
Garcia-Larsen V, Ierodiakonou D, Jarrold K, Cunha S, Chivinge J, Robinson Z, Geoghegan N, Ruparelia A, Devani P, Trivella M, Leonardi-Bee J, Boyle RJ. Garcia-Larsen V, et al. PLoS Med. 2018 Feb 28;15(2):e1002507. doi: 10.1371/journal.pmed.1002507. eCollection 2018 Feb. PLoS Med. 2018. PMID: 29489823 Free PMC article.
Evidence from 19 intervention trials suggests that oral supplementation with nonpathogenic micro-organisms (probiotics) during late pregnancy and lactation may reduce risk of eczema (Risk Ratio [RR] 0.78; 95% CI 0.68-0.90; I2 = 61%; Absolute Risk Reduction 44 cases per 1,000; 95% …
Evidence from 19 intervention trials suggests that oral supplementation with nonpathogenic micro-organisms (probiotics) during late pregnanc …
Fenofibrate for diabetic retinopathy.
Kataoka SY, Lois N, Kawano S, Kataoka Y, Inoue K, Watanabe N. Kataoka SY, et al. Cochrane Database Syst Rev. 2023 Jun 13;6(6):CD013318. doi: 10.1002/14651858.CD013318.pub2. Cochrane Database Syst Rev. 2023. PMID: 37310870 Review.
MAIN RESULTS: We included two studies and their eye sub-studies (15,313 participants) in people with T2D. The studies were conducted in the US, Canada, Australia, Finland, and New Zealand; follow-up period was four to five years. ...The use of fenofibrate increased severe …
MAIN RESULTS: We included two studies and their eye sub-studies (15,313 participants) in people with T2D. The studies were conducted …
Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
Maiorino MI, Signoriello S, Maio A, Chiodini P, Bellastella G, Scappaticcio L, Longo M, Giugliano D, Esposito K. Maiorino MI, et al. Diabetes Care. 2020 May;43(5):1146-1156. doi: 10.2337/dc19-1459. Diabetes Care. 2020. PMID: 32312858
DATA SYNTHESIS: All results were analyzed by a random effects model to calculate the weighted mean difference (WMD) with the 95% CI. We identified 15 RCTs, lasting 12-36 weeks and involving 2,461 patients. Compared with the usual care (overall data), CGM was associated wit …
DATA SYNTHESIS: All results were analyzed by a random effects model to calculate the weighted mean difference (WMD) with the 95% CI. We iden …
Diabetes mellitus and adverse outcomes after carotid endarterectomy: A systematic review and meta-analysis.
Li F, Zhang R, Di X, Niu S, Rong Z, Liu C, Ni L. Li F, et al. Chin Med J (Engl). 2023 Jun 20;136(12):1401-1409. doi: 10.1097/CM9.0000000000002730. Epub 2023 May 22. Chin Med J (Engl). 2023. PMID: 37334731 Free PMC article.
Regarding the short-term outcomes, DM was associated with increased risks of MAEs (ES = 1.52, 95% CI: [1.15-2.01], prevalence = 5.1%), death/stroke (ES = 1.61, 95% CI: [1.13-2.28], prevalence = 2.3%), stroke (ES = 1.55, 95% CI: [1.16-1.55], prevalence = 3.5%), death (ES = …
Regarding the short-term outcomes, DM was associated with increased risks of MAEs (ES = 1.52, 95% CI: [1.15-2.01], prevalence = 5.1%) …
194 results